Projects
Innovative point-of-care molecular diagnostics for surveillance and targeted control of schistosomiasis and malaria in DR Congo (based on environmental DNA) KU Leuven
Vector-borne diseases are a major global public health burden, affecting more than 1 billion people worldwide. Malaria and schistosomiasis are the main causes of morbidity and mortality, especially children and pregnant women in developing countries. They are transmitted by vectors (mosquito and snail, respectively), whose life cycles include an aquatic stage, resulting therefore in overlapping distributions and thus coinfections. Therefore, ...
Joint R&D 2023: Translating Alzheimer’s molecular biology of cognitive decline to improve diagnostics and therapeutics Vrije Universiteit Brussel
Development and integration of serological and molecular diagnostics in view of interruption of transmission of gambiense-HAT Institute of Tropical Medicine
Molecular characterization and vaccine matching studies of circulating strains of Infectious Bursal Disease Virus (IBDV) in Ethiopia for improved diagnostics and vaccination strategies KU Leuven
In Ethiopia, infectious bursal disease was first reported in 2002 in a privately owned commercial poultry farm in Bishoftu town. Subsequently, it became one of the most important diseases affecting the national poultry industry. Research findings and case reports from various regions of the country showed the occurrence of outbreaks of IBD in commercial farms, breeding and multiplication centers despite regular vaccination practices and ...
MOLECULAR DIAGNOSTICS IN AUTISM SPECTRUM DISORDER: NEXT GENERATION SEQUENCING AND FACIAL PHENOTYPING IN MEDICAL GENETICS KU Leuven
Despite considerable progress in the genetics of autism spectrum disorder (ASD) in the past decade, molecular diagnostics for patients with ASD remains a great challenge due to the complex genetic architecture of ASD. In clinical genetics, an etiological distinction is usually made between ASD patients with Mendelian causes (i.e. driven by a highly penetrant rare variant) and patients with multifactorial causes (i.e. driven by many genetic ...